Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells

Circulation Research

Volumn 83, Issue 3, 1998, Pages 322-327

  Kume, Noriaki ^a   Murase, Takatoshi ^a   Moriwaki, Hideaki ^a   Aoyama, Takuma ^a   Sawamura, Tatsuya ^a   Masaki, Tomoh ^a   Kita, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cytokine; Phorbol myristate acetate; Tumor necrosis factor

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE PERCHLORIC ACID; ACETYL LOW DENSITY LIPOPROTEIN; CELL SURFACE RECEPTOR; LECTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; REAGENT; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CATTLE; CHO CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032504764     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.3.322     Document Type: Article

References (37)

1. Gimbrone MA Jr, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium: an integrator of pathophysiological stimuli in atherogenesis. Ann N Y Acad Sci. 1995;748:122-132.
2. Libby P, Hansson GK. Involvement of immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991; 64:5-15.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
4. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
5. Chisolm GM. Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Lab Invest. 1993; 68:369-371.
6. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
7. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994;93:907-911.
8. Zembowicz A, Tang JL, Wu KK. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem. 1995;270:17006-17010.
9. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res. 1995;76:958-962.
10. Zembowicz A, Jones SL, Wu KK. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest. 1995;96:1688-1692.
11. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry P. Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
12. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994;14:1007-1013.
13. Murugesan G, Fox PL. Role of lysophoshpatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest. 1996;97:2736-2744.
14. Kume N, Arai H, Kawai C, Kita T. Receptors for modified low-density lipoproteins in human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim Biophys Acta. 1991;1091:63-67.
15. van Berkel TJC, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. J Biol Chem. 1991;266:2282-2289.
16. de Rijke YB, van Berkel TJC. Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins. J Biol Chem. 1994;269:824-827.
17. Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D. Molecular flypaper, host defence, and atherosclerosis. J Biol Chem. 1993;268:4569-4572.
18. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 1990;343:531-535.
19. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 1990;343:570-572.
20. Stanton LW, White RT, Bryant CM, Protter AA, Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 1992;267:22446-22451.
21. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
22. Acton SL, Scherer PE, Lodish HE, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem. 1994; 269:21003-21009.
23. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognize oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A. 1995;92:9580-9584.
24. Bickel PE, Freeman M. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest. 1992;90:1450-1457.
25. Sawamura T, Kume N, Aoyama T, Moriwaki H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. A novel endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-77.
26. Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol. 1993;142:1721-1728.
27. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Tumor necrosis factor gene expression in human vascular intimai smooth muscle cells detected by in situ hybridization. Am J Pathol. 1990;137: 503-509.
28. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859-1867.
29. Stephan ZF, Yirachek EC. Rapid fluorometric assay of LDL receptor activity by Oil-labeled LDL. J Lipid Res. 1993;34:325-330.
30. Tanaka H, Sukhova G, Schwanz D, Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol. 1996;16:12-18.
31. Tanaka H, Swanson SJ, Sukhova G, Schoen FJ, Libby P. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol. 1995;147:617-626.
32. Pitas RE. Expression of the acetylated low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells: up-regulation by phorbol esters. J Biol Chem. 1990;265:12722-12727.
33. Li H, Freeman MW, Libby P. Regulation of smooth muscle scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest. 1995;95:122-133.
34. Van Lenten BJ, Fogelman AM. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-α. J Immunol. 1992;148:112-116.
35. Hsu HY, Nicholson AC, Hajjar DP. Inhibition of macrophage scavenger activity by tumor necrosis factor-α is transcriptionally and post-transcriptionally regulated. J Biol Chem. 1996;271:7767-7773.
36. Geng Y, Hansson GK. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte derived macrophages. J Clin Invest. 1992;89:1322-1330.
37. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol. 1996;16:1019-1025.